CL2014000756A1 - Composicion para ser aplicada a la piel que comprende un vehiculo dermatologicamente compatible, aceite de coco, de avellana y de ortiga y el uso de la misma en enfermedades a la piel. - Google Patents

Composicion para ser aplicada a la piel que comprende un vehiculo dermatologicamente compatible, aceite de coco, de avellana y de ortiga y el uso de la misma en enfermedades a la piel.

Info

Publication number
CL2014000756A1
CL2014000756A1 CL2014000756A CL2014000756A CL2014000756A1 CL 2014000756 A1 CL2014000756 A1 CL 2014000756A1 CL 2014000756 A CL2014000756 A CL 2014000756A CL 2014000756 A CL2014000756 A CL 2014000756A CL 2014000756 A1 CL2014000756 A1 CL 2014000756A1
Authority
CL
Chile
Prior art keywords
skin
nettle
hazelnut
diseases
composition
Prior art date
Application number
CL2014000756A
Other languages
English (en)
Inventor
Ali Nahavandi
Original Assignee
Alnapharm Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alnapharm Gmbh & Co Kg filed Critical Alnapharm Gmbh & Co Kg
Publication of CL2014000756A1 publication Critical patent/CL2014000756A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CL2014000756A 2011-09-30 2014-03-27 Composicion para ser aplicada a la piel que comprende un vehiculo dermatologicamente compatible, aceite de coco, de avellana y de ortiga y el uso de la misma en enfermedades a la piel. CL2014000756A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11007992.8A EP2574343B1 (de) 2011-09-30 2011-09-30 Zusammensetzung zum Auftragen auf die Haut und Verwendung derselben

Publications (1)

Publication Number Publication Date
CL2014000756A1 true CL2014000756A1 (es) 2014-10-03

Family

ID=46851932

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014000756A CL2014000756A1 (es) 2011-09-30 2014-03-27 Composicion para ser aplicada a la piel que comprende un vehiculo dermatologicamente compatible, aceite de coco, de avellana y de ortiga y el uso de la misma en enfermedades a la piel.

Country Status (33)

Country Link
US (1) US20140234447A1 (es)
EP (1) EP2574343B1 (es)
JP (1) JP6034386B2 (es)
KR (1) KR101954057B1 (es)
CN (1) CN103841986B (es)
AP (1) AP2014007596A0 (es)
AU (1) AU2012314946B2 (es)
BR (1) BR112014007218B1 (es)
CA (1) CA2848922C (es)
CL (1) CL2014000756A1 (es)
CO (1) CO6930361A2 (es)
CY (1) CY1115039T1 (es)
DK (1) DK2574343T3 (es)
EA (1) EA023746B1 (es)
ES (1) ES2458124T3 (es)
GE (1) GEP20166495B (es)
GT (1) GT201400058A (es)
HR (1) HRP20140386T1 (es)
IL (1) IL231589B (es)
MX (1) MX349493B (es)
MY (1) MY184014A (es)
PE (1) PE20141538A1 (es)
PH (1) PH12014500631B1 (es)
PL (1) PL2574343T3 (es)
PT (1) PT2574343E (es)
RS (1) RS53289B (es)
SG (1) SG11201400742PA (es)
SI (1) SI2574343T1 (es)
SM (1) SMT201400051B (es)
TN (1) TN2014000102A1 (es)
UA (1) UA113065C2 (es)
WO (1) WO2013045031A1 (es)
ZA (1) ZA201401941B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20131053A1 (it) * 2013-06-25 2014-12-26 Maria Oliva Salviati Composizione che comprende ortica

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5381612A (en) * 1976-12-24 1978-07-19 Fuarumatsuoiteitsushiyu Fuabur Ointment for treating psoriasis vulgaris * lichen and eczema
DE3232136A1 (de) * 1982-08-28 1984-03-01 Ruth Cegla GmbH, 7542 Schömberg Gemisch enthaltend meersalz und/oder salinensalz
MC2056A1 (fr) * 1987-12-23 1990-09-04 Psoricur Ltd Composition therapeutique contre le psoriasis,procede pour sa preparation et utilisation de plantes medicinales qu'elle contient
US5376361A (en) * 1993-01-13 1994-12-27 Perricone; Nicholas V. Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage
DE19504914C1 (de) * 1995-02-15 1995-11-16 Goldwell Gmbh Haarwaschmittel
US6752999B2 (en) * 1995-09-20 2004-06-22 Nicholas V. Perricone Method of skin care and/or treatment using lipoic acid
RU2127584C1 (ru) * 1996-02-29 1999-03-20 Коновалов Валерий Николаевич Мазь противовоспалительного, обезболивающего и ранозаживляющего действия (варианты)
RO113110B1 (ro) * 1997-02-13 1998-04-30 Sc Apollo Sa Săpun extrafin
US5997889A (en) * 1998-02-20 1999-12-07 Omnipotent Skin Products, L.L.C. Hand and body creme for the treatment of skin ailments
AU2001249510A1 (en) * 2000-03-27 2001-10-08 Schott Glas New cosmetic, personal care, cleaning agent, and nutritional supplement compositions comprising bioactive glass and methods of making and using the same
US6673756B2 (en) * 2000-09-20 2004-01-06 Symrise Gmbh & Co. Kg Multiphase soaps
ITRM20030204A1 (it) * 2003-04-29 2004-10-30 Provincia Italiana Della Congregazi One Dei Figli Formulazione dermatologica.
US7060306B2 (en) * 2003-11-10 2006-06-13 Springstead Patricia R Skin formulation
US7390507B2 (en) * 2004-04-13 2008-06-24 Ruwart Mary J Compositions and methods for the treatment of radiation burns and other traumatic skin conditions
FR2888497B1 (fr) * 2005-07-13 2010-12-24 Oreal Procede de maquillage et/ou de soin cosmetique
US20080113033A1 (en) * 2006-11-13 2008-05-15 Hrk, Inc. Topical treatment and manufacturing method
DE102007036499A1 (de) * 2007-08-01 2009-02-05 Henkel Ag & Co. Kgaa Naturkosmetisches Haarbehandlungsmittel
FR2956813B1 (fr) * 2010-02-26 2012-07-27 Lea Lab Shampooing et son utilisation

Also Published As

Publication number Publication date
PE20141538A1 (es) 2014-11-18
PH12014500631A1 (en) 2014-05-12
BR112014007218B1 (pt) 2020-12-15
DK2574343T3 (da) 2014-04-28
PT2574343E (pt) 2014-05-02
PL2574343T3 (pl) 2014-07-31
HRP20140386T1 (hr) 2014-08-01
EA023746B1 (ru) 2016-07-29
MX349493B (es) 2017-08-01
BR112014007218A2 (pt) 2017-04-04
CA2848922C (en) 2020-04-07
IL231589A0 (en) 2014-05-28
JP2014527990A (ja) 2014-10-23
EP2574343B1 (de) 2014-01-29
CN103841986B (zh) 2019-09-03
ZA201401941B (en) 2015-09-30
EP2574343A1 (de) 2013-04-03
KR20140090985A (ko) 2014-07-18
CA2848922A1 (en) 2013-04-04
SMT201400051B (it) 2014-07-07
WO2013045031A1 (en) 2013-04-04
NZ623817A (en) 2015-07-31
SI2574343T1 (sl) 2014-06-30
SG11201400742PA (en) 2014-04-28
CY1115039T1 (el) 2016-12-14
MY184014A (en) 2021-03-17
RS53289B (sr) 2014-08-29
US20140234447A1 (en) 2014-08-21
AP2014007596A0 (en) 2014-04-30
GEP20166495B (en) 2016-06-27
TN2014000102A1 (en) 2015-07-01
HK1197037A1 (en) 2015-01-02
ES2458124T3 (es) 2014-04-30
JP6034386B2 (ja) 2016-11-30
EA201400399A1 (ru) 2014-07-30
PH12014500631B1 (en) 2018-10-31
MX2014003846A (es) 2015-01-16
GT201400058A (es) 2015-10-15
KR101954057B1 (ko) 2019-05-22
UA113065C2 (xx) 2016-12-12
CO6930361A2 (es) 2014-04-28
AU2012314946B2 (en) 2017-06-15
AU2012314946A1 (en) 2014-05-15
CN103841986A (zh) 2014-06-04
IL231589B (en) 2019-07-31

Similar Documents

Publication Publication Date Title
CO6831975A2 (es) Inmunoconjugados, composiciones para prepararlos, métodos para prepararlos y uso
CL2015000128A1 (es) Composición para controlar enfermedades en plantas y el uso de la misma
PT2612551E (pt) Composição de ácaros compreendendo um ácaro predador e presa imobilizada, em contacto com um agente de redução de fungos e métodos e usos relacionados com o uso da referida composição
BR112013016299A2 (pt) artigo abrasivo; e método para formar o mesmo
CL2015000345A1 (es) Uso de una combinación para el melanoma que comprende la administración de cobimetinib y vemurafenib.
CR9503A (es) Concentrado para suspender en aceites
BR112013004025A2 (pt) amarra para uso hortícola
BR112013001423A2 (pt) método, método in vitro, uso e kit útil para realizar o método
CL2014000050A1 (es) Composicion farmaceutica en forma de solucion que comprende apomorfina, un codisolvente micible en agua, un antioxidante y agua, en la que el ph es superior a 4; procedimiento para fabricarla; y su uso como solucion inyectable en el tratamiento de la enfermedad de parkinson.
EP2630948A4 (en) OIL-IN-WATER EXTERNAL PREPARATION FOR SKIN CARE
EP2903627A4 (en) NON-LUBRICANT LUBRICANT COMPOSITIONS WITH SENSORY ACTIVE SUBSTANCES
CL2013002052A1 (es) Uso de quitosanos para aumentar el ritmo de crecimiento de la uña (divisional de la sol. 444-08).
CL2014002221A1 (es) Composiciones y métodos para aplicar de manera precisa un agente bioactivo a organismos acuáticos.
CL2014001834A1 (es) Uso de semilla de palta con el fin de obtener mediante presion mecanica aceite de palta enriquecido en alquil polioles, donde dichas semillas representan el 10 al 50% en peso en relacion con el peso total de la palta utilizada; metodo para obtener aceite de palta; y aceite de palta enriquecido; uso de aceite de palta; e insaponificable de palta.
MX385118B (es) Aceite reforzador para composición de la piel.
CL2014000992A1 (es) Preparacion de liberacion sostenida que comprende pioglitazona o una sal de esta; metodo de preparacion; uso para prevenir y/o retardar el inicio o suprimir la progresion de la enfermedad de alzheimer.
BRPI0810521A2 (pt) Pelotas autofundentes apra alto-forno e método para produzir as mesmas.
CL2014000792A1 (es) Composicion para uso en la promocion de absorcion de magnesio y/o retencion de magnesio
BR112015006960A2 (pt) uso de uma combinação, composição e método para preparar um produto de espuma
CL2013001594A1 (es) Articulo absorbente que comprende un compuesto de estimulo; un compuesto de estimulo; y metodo para hacer un compuesto de estimulo.
BR112014013033A2 (pt) composição microbicida, composição de barra de sabão, método para fornecer um efeito microbicida para a pele e uso da composição
CL2015000785A1 (es) Composición grasa que comprende una primera y una segunda mezcla de aceites refinados e interesterificados, donde la primera mezcla comprende aceite de palma, aceite de palmiste y aceite de coco, y donde la segunda mezcla comprende aceite de palma hidrogenado, aceite de palmiste hidrogenado y aceite de coco hidrogenado.
CO7071125A2 (es) Composiciones, síntesis y métodos para el uso de derivados de fenilcicloalquilmetilamino
CO6950489A2 (es) Formulación agroquímica y uso de la misma
CL2013000902A1 (es) Composición en forma de gránulos peletizados a base de esporas y arcillas minerales ; proceso para obtener dicha composición.